These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 12711408)

  • 21. Vesicular stomatitis virus glycoprotein is a determinant of pathogenesis in swine, a natural host.
    Martinez I; Rodriguez LL; Jimenez C; Pauszek SJ; Wertz GW
    J Virol; 2003 Jul; 77(14):8039-47. PubMed ID: 12829843
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Emergence and re-emergence of vesicular stomatitis in the United States.
    Rodríguez LL
    Virus Res; 2002 May; 85(2):211-9. PubMed ID: 12034487
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Repeated transfer of small RNA virus populations leading to balanced fitness with infrequent stochastic drift.
    Novella IS; Elena SF; Moya A; Domingo E; Holland JJ
    Mol Gen Genet; 1996 Oct; 252(6):733-8. PubMed ID: 8917317
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evolution of fitness in experimental populations of vesicular stomatitis virus.
    Elena SF; González-Candelas F; Novella IS; Duarte EA; Clarke DK; Domingo E; Holland JJ; Moya A
    Genetics; 1996 Mar; 142(3):673-9. PubMed ID: 8849878
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Matrix protein mediated shutdown of host cell metabolism limits vesicular stomatitis virus-induced interferon-alpha responses to plasmacytoid dendritic cells.
    Waibler Z; Detje CN; Bell JC; Kalinke U
    Immunobiology; 2007; 212(9-10):887-94. PubMed ID: 18086387
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rearrangement of the genes of vesicular stomatitis virus eliminates clinical disease in the natural host: new strategy for vaccine development.
    Flanagan EB; Zamparo JM; Ball LA; Rodriguez LL; Wertz GW
    J Virol; 2001 Jul; 75(13):6107-14. PubMed ID: 11390612
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of a consensus mutation in M protein of vesicular stomatitis virus from persistently infected cells that affects inhibition of host-directed gene expression.
    Ahmed M; Lyles DS
    Virology; 1997 Oct; 237(2):378-88. PubMed ID: 9356348
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reconstruction experiments demonstrating selective effects of defective interfering particles on mixed populations of vesicular stomatitis virus.
    Horodyski FM; Holland JJ
    J Gen Virol; 1984 Apr; 65 ( Pt 4)():819-23. PubMed ID: 6323624
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Distributions of epistasis in microbes fit predictions from a fitness landscape model.
    Martin G; Elena SF; Lenormand T
    Nat Genet; 2007 Apr; 39(4):555-60. PubMed ID: 17369829
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A hemi-nested PCR assay for the detection and identification of vesicular stomatitis virus nucleic acid.
    Höfner MC; Carpenter WC; Ferris NP; Kitching RP; Ariza Botero F
    J Virol Methods; 1994 Dec; 50(1-3):11-20. PubMed ID: 7714033
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Negative effect of genetic bottlenecks on the adaptability of vesicular stomatitis virus.
    Novella IS
    J Mol Biol; 2004 Feb; 336(1):61-7. PubMed ID: 14741203
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Arrested spread of vesicular stomatitis virus infections in vitro depends on interferon-mediated antiviral activity.
    Lam V; Duca KA; Yin J
    Biotechnol Bioeng; 2005 Jun; 90(7):793-804. PubMed ID: 15834946
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD4 T cells inhibit the CD8 T cell response during low-dose virus infection.
    Cose S; Brammer C; Zammit DJ; Blair DA; Lefrançois L
    Int Immunol; 2006 Aug; 18(8):1285-93. PubMed ID: 16769750
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recombinant vesicular stomatitis (Indiana) virus expressing New Jersey and Indiana glycoproteins induces neutralizing antibodies to each serotype in swine, a natural host.
    Martinez I; Barrera JC; Rodriguez LL; Wertz GW
    Vaccine; 2004 Sep; 22(29-30):4035-43. PubMed ID: 15364454
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Virology. Evolving Darwinism.
    Brookfield JF
    Nature; 1995 Aug; 376(6541):551-2. PubMed ID: 7637798
    [No Abstract]   [Full Text] [Related]  

  • 36. Variability in mutational fitness effects prevents full lethal transitions in large quasispecies populations.
    Sardanyés J; Simó C; Martínez R; Solé RV; Elena SF
    Sci Rep; 2014 Apr; 4():4625. PubMed ID: 24713667
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of immunological paradigms in a virus model: are dendritic cells critical for antiviral immunity and viral clearance?
    Ciavarra RP; Stephens A; Nagy S; Sekellick M; Steel C
    J Immunol; 2006 Jul; 177(1):492-500. PubMed ID: 16785546
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The variety of human virus evolution.
    Fitch WM
    Mol Phylogenet Evol; 1996 Feb; 5(1):247-58. PubMed ID: 8673293
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Superantigen-activated T cells redirected by a bispecific antibody inhibit vesicular stomatitis virus replication in vitro and in vivo.
    Fernandez-Sesma A; Peluso RW; Bai X; Schulman JL; Levy DE; Moran TM
    J Immunol; 1998 Feb; 160(4):1841-9. PubMed ID: 9469445
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The earliest events in vesicular stomatitis virus infection of the murine olfactory neuroepithelium and entry of the central nervous system.
    Plakhov IV; Arlund EE; Aoki C; Reiss CS
    Virology; 1995 May; 209(1):257-62. PubMed ID: 7747478
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.